These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. New aspects in the pathogenesis of diabetic atherothrombosis. Moreno PR; Fuster V J Am Coll Cardiol; 2004 Dec; 44(12):2293-300. PubMed ID: 15607389 [TBL] [Abstract][Full Text] [Related]
23. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Tan KT; Tayebjee MH; Lim HS; Lip GY Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308 [TBL] [Abstract][Full Text] [Related]
24. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
25. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Beckman JA; Creager MA; Libby P JAMA; 2002 May; 287(19):2570-81. PubMed ID: 12020339 [TBL] [Abstract][Full Text] [Related]
26. Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis. Gerster H Z Ernahrungswiss; 1993 Dec; 32(4):243-61. PubMed ID: 8128746 [TBL] [Abstract][Full Text] [Related]
27. Platelet in progression of atherosclerosis: a potential target in diabetic patients. Koyama H; Nishizawa Y Curr Diabetes Rev; 2005 May; 1(2):159-65. PubMed ID: 18220591 [TBL] [Abstract][Full Text] [Related]
29. Vascular growth factors and the development of macrovascular disease in diabetes mellitus. Koschinsky T; Bünting CE; Rütter R; Gries FA Diabete Metab; 1987 Jul; 13(3 Pt 2):318-25. PubMed ID: 3308559 [TBL] [Abstract][Full Text] [Related]
30. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Munro JM; Cotran RS Lab Invest; 1988 Mar; 58(3):249-61. PubMed ID: 3279259 [TBL] [Abstract][Full Text] [Related]
31. Atherosclerosis, the major complication of diabetes. Steiner G Adv Exp Med Biol; 1985; 189():277-97. PubMed ID: 4036715 [No Abstract] [Full Text] [Related]
33. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. Ip JH; Fuster V; Badimon L; Badimon J; Taubman MB; Chesebro JH J Am Coll Cardiol; 1990 Jun; 15(7):1667-87. PubMed ID: 2188991 [TBL] [Abstract][Full Text] [Related]
34. Role of platelets in the development of atherosclerotic disease and possible interference with platelet inhibitor drugs. Fuster V Scand J Haematol Suppl; 1981; 38():1-38. PubMed ID: 7038856 [TBL] [Abstract][Full Text] [Related]
35. From hemobiology to vascular disease: a review of the potential of gliclazide to influence the pathogenesis of diabetic vascular disease. Jennings PE J Diabetes Complications; 1994; 8(4):226-30. PubMed ID: 7833498 [TBL] [Abstract][Full Text] [Related]
36. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus. Soma P; Pretorius E Cardiovasc Diabetol; 2015 Jul; 14():96. PubMed ID: 26228646 [TBL] [Abstract][Full Text] [Related]
37. [Physiopathology of atherosclerosis in diabetics]. Tedgui A Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():13-6. PubMed ID: 15666476 [TBL] [Abstract][Full Text] [Related]
39. The mystery of diabetes and atherosclerosis: time for a new plot. Semenkovich CF; Heinecke JW Diabetes; 1997 Mar; 46(3):327-34. PubMed ID: 9032085 [TBL] [Abstract][Full Text] [Related]